At-Home STI Testing Pilot Shows Promise for Remote Sexual Health Screening
Canadian study demonstrates feasibility of comprehensive at-home testing for sexually transmitted infections with 43% kit return rate.
Summary
Researchers in Calgary tested a fully remote, web-based platform for sexually transmitted and blood-borne infection (STBBI) screening. Of 156 participants who enrolled online, 67 (43%) returned self-collected samples including swabs, urine, and dried blood spots. Six participants (9%) tested positive for new infections and all received appropriate treatment. Participants reported high satisfaction with the platform, though dried blood spot collection proved challenging. The study demonstrates that comprehensive at-home STBBI testing is feasible and could help reduce barriers to sexual health screening, particularly for populations facing stigma or limited healthcare access.
Detailed Summary
Rising rates of sexually transmitted and blood-borne infections (STBBIs) combined with barriers like stigma and healthcare access challenges have created an urgent need for innovative screening approaches. Canadian researchers developed and tested the first fully remote STBBI testing program in the country, offering comprehensive at-home screening through a web-based platform.
The pilot study enrolled 156 participants (mean age 37.3 years, 39.7% men) from diverse sexual and gender backgrounds between February 2023 and March 2024. Participants completed online intake questionnaires covering demographics and sexual health history, then received personalized testing kits based on their reported sexual practices. The kits included materials for multi-site bacterial STI testing (chlamydia and gonorrhea via swabs and urine) and dried blood spot cards for HIV, hepatitis C, and syphilis screening.
Of those who received kits, 67 participants (43%) completed self-collection and returned samples. The cohort showed concerning risk factors: over 50% reported low condom use and 40% hadn't been tested for STBBIs in the past year. Testing identified six participants (9.0%) with new positive results, all of whom were successfully connected to appropriate treatment. Bacterial STI testing was performed locally using validated molecular assays, while blood-borne pathogen testing utilized established dried blood spot methods at the National Microbiology Laboratory.
Participants reported high satisfaction with the web-based platform and testing process overall. Most collection methods were rated as easy to use, though dried blood spot collection via fingerstick presented notable challenges for users. Results were communicated securely via participants' preferred method (SMS or email), with negative results automated and positive results requiring manual contact for disclosure and care coordination.
The study demonstrates that comprehensive remote STBBI testing is both feasible and acceptable, potentially addressing significant barriers to sexual health screening. However, the 43% kit return rate suggests room for improvement in engagement strategies, and dried blood spot collection methods may need refinement for broader implementation.
Key Findings
- 43% of enrolled participants (67 of 156) successfully completed and returned self-collected testing kits
- 9.0% of tested participants (6 of 67) had new positive STBBI results, all connected to treatment
- Over 50% of participants reported low condom use in their sexual practices
- 40% of participants had not undergone STBBI testing in the previous 12 months
- Participants reported high satisfaction with web-based platform and most collection methods
- Dried blood spot collection via fingerstick presented notable usability challenges
- Mean participant age was 37.3 years with diverse representation across gender and sexual orientations
Methodology
Prospective cohort study of 156 Alberta residents aged ≥16 years who self-enrolled through a web-based platform between February 2023-March 2024. Participants completed online intake questionnaires and received personalized testing kits based on sexual practices. Bacterial STI testing used APTIMA molecular assays, while HIV/HCV/syphilis testing employed validated dried blood spot methods. Statistical analysis included descriptive statistics and comparison of kit return rates across demographic groups using appropriate tests.
Study Limitations
The 43% kit return rate indicates significant attrition between enrollment and completion. Dried blood spot collection proved challenging for participants, potentially limiting the feasibility of comprehensive blood-borne pathogen screening. The study was limited to Alberta residents and may not be generalizable to other regions. Sample size was relatively small for a pilot study, and longer-term follow-up data on treatment outcomes and repeat testing behaviors were not available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.